Share on StockTwits

Dentsply International (NASDAQ:XRAY)‘s stock had its “neutral” rating reaffirmed by Zacks in a research report issued to clients and investors on Friday. They currently have a $49.00 price objective on the stock. Zacks‘s target price suggests a potential upside of 5.56% from the stock’s previous close.

Zacks’ analyst wrote, “DENTSPLY’s second-quarter 2014 earnings per share grew 4.5% to $0.69, beating the Zacks Consensus Estimate by a penny. Net revenues upped only 0.6% to $765.2 million but missed the Zacks Consensus Estimate by $14.8 million. Sluggish market in both the U.S. and Europe hurt the company’s revenue growth. However, we believe a diversified product range and significant investments in product innovation should help the company expand its share in the dental market. Management expects a 5.1-8.5% rise in earnings per share in 2014 based on better global market conditions. As such, we reaffirm our Neutral recommendation on DENTSPLY with a target of $49.00.”

Shares of Dentsply International (NASDAQ:XRAY) traded up 0.15% during mid-day trading on Friday, hitting $46.49. The stock had a trading volume of 278,132 shares. Dentsply International has a 52 week low of $41.31 and a 52 week high of $50.99. The stock’s 50-day moving average is $47.37 and its 200-day moving average is $46.42. The company has a market cap of $6.592 billion and a P/E ratio of 21.39.

Dentsply International (NASDAQ:XRAY) last announced its earnings results on Thursday, July 31st. The company reported $0.69 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.68 by $0.01. The company had revenue of $765.20 million for the quarter, compared to the consensus estimate of $782.86 million. During the same quarter last year, the company posted $0.66 earnings per share. Dentsply International’s revenue was up .6% compared to the same quarter last year. On average, analysts predict that Dentsply International will post $2.52 earnings per share for the current fiscal year.

Separately, analysts at Barrington Research upgraded shares of Dentsply International from a “market perform” rating to an “outperform” rating in a research note on Friday, May 16th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $51.00.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.